McKeand Moves to UK Pension Fund Asset Owners, Equities AustralianSuper’s former Head of Equities, Innes McKeand, has left to join UK Pension Fund USS, where he will establish a new global equities team. Read More
Beware of the SPAC Frenzy Equities, Private & Alternative Markets SPAC investments have become all the rage, with almost as much money raised in the US as traditional IPOs. But not every investor is set to make money from these vehicles. ‘Caveat Emptor’, Sameer Jain warns. Read More
Value in Emerging Markets Emerging Markets, Equities Value investing has experienced a resurgence in the past four weeks. We talk to T Rowe Price’s Ernest Yeung about what this means for emerging markets. Read More
Raising Awareness of ESG Materiality Equities, ESG In this interview with Trillium’s Matt Patsky, we tackle some of the most contentious ESG issues, including the gender pay gap and the decline of fossil fuel demand. We also look at how investors can use shareholder resolutions to raise awareness of issues that are ignored by companies. Read More
Value Rotation in Emerging Markets Emerging Markets, Equities It currently appears that we have a bubble in technology stocks, as in 2001. But this time round, it is combined with a deep global recession and a heightened focus on sustainability. Read More
Technology Stocks Could Face Headwinds Equities Technology companies, the drivers of the outperformance of growth-style investing in recent years, are facing several headwinds and investors should be wary if their portfolios are too heavily skewed to growth, Cambridge Associates’ Travis Schoenleber says Read More
Climate Transition: Beyond Low Carbon Investing Equities, ESG In partnership with Aviva Investors, [i3] convened a webinar to discuss the implications of climate transition to investors’ portfolios. With combined backgrounds in Environmental Biology, Environmental Technology and Finance, Rick Stathers and Jaime Ramos Martin shared their perspectives on how investors can go beyond low carbon investing to build resilience into portfolios. Key issues included: The […] Read More
Pharma Unlikely to Strike Gold with Vaccine Equities, Financial Crisis A COVID-19 vaccine might not prove to be a watershed moment for the pharmaceutical industry, but there are plenty of other opportunities, Capital Group says Read More
Investing in Global Champions Equities, Innovation How can investors navigate global equity markets during this volatile period? What does this mean for globalisation and for long-term investors? Jonathan Knowles shared his perspectives on medical innovation in the context of COVID-19. Read More
![[i3] Emerging Markets Webinar with T. Rowe Price](https://i3-invest.com/wp-content/uploads/2020/12/i3-EM-Webinar-with-T-Rowe-Price-2-680x383.jpg)
![[i3] Climate Transition with Aviva Investors](https://i3-invest.com/wp-content/uploads/2020/12/i3-Climate-Transition-Webinar-with-Aviva-Investors-Speakers-680x383.jpg)
